BBiibblliiooggrraapphhyy

Bibliography

127

VN’s Lab, BDU

Bibliography

Abe A, Hiraoka M and Shayman JA (2006). Positional specificity of lysosomal phospholipase A2. J. Lipid Res. 47: 2268–2279.

Abe AM, Hiraoka S, Wild SE, Wilcoxen R, Paine III, and Shayman JA (2004). Lysosomal phospholipase A2 is selectively expressed in alveolar macrophages. J. Biol. Chem. 279: 42605–42611. Abraham E, Matthey MA, Dinalello CA (2000). Consensus conference definitions for sepsis, septic shock, acute lung injury and acute respiratory distress syndrome. Crit. Care Med. 28: 232–235. Ackerman SJ, Kwatia MA, Doyle CB, et al (2003). Hydrolysis of surfactant phospholipids catalized by phospholipases A2 and eosinophil lysophospholipases causes surfactant dysfunction.

Chest.123: 355S. Alavanja M C 2002. Biologic damage resulting from exposure to tobacco smoke and from radon: implication for preventive interventions; Oncogene, 21 7365-7375. Allen JN, Moore SA, Pope-Harman AL, Marsh CB and Wewers MD (1995). Immunosuppressive properties of surfactant and plasma on alveolar macrophages. J Lab Clin Med. 125: 356–369. Anderson BO, Moore EE, Banerjee A (1994). Phospholipase A2 regulates critical inflammatory mediators of multiple organ Failure. J. Surg. Res. 56: 199–205. Aoshiba K, Koinuma M, Yokohori N, Nagai A (2003). Immunohistochemical evaluation of oxidative stress in murine lungs after cigarette smoke exposure. Inhal Toxicol 15: 1029-1038. Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, Havet N, Longacre S, Vargaftig BB, Béréziat G, Voelker DR, Wolf C, Touqui L (1998). Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. J. Clin. Investig. 102: 1152–1160. Arbibe L, Vial D and Touqui L (1997). Phospholipase A2 and acute respiratory distress syndrome.

Prog Surg 24: 79–87. Arbibe L, Vial D, Rosinski-Chupin I, Havet N, Huerre M, Vargaftig BB, Touqui L (1997). Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysaccharide-induced type II phospholipase A2 synthesis. J. Immunol. 159: 391–400. Arbibe L., D. Vial, L. Touqui, Phospholipase A2 and acute respiratory distress syndrome, Prog. Surg. 24 (1997) 79–87. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967). Acute respiratory distress in adults. Lancet 2: 319–323. Athenstaedt K, Daum G (1999). Phosphatidic acid, a key intermediate in lipid metabolism. Eur J Biochem. 266:1-16.

Bibliography

128

VN’s Lab, BDU

Avery ME, Mead J (1959). Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 97: 517-523. Balboa MA, Pérez R, Balsinde J (2003). Amplification mechanisms of inflammation: paracrine stimulation of arachidonic acid mobilization by secreted phospholipase A2 is regulated by cytosolic phospholipase A2-derived hydroperoxyeicosatetraenoic acid. J Immunol. 171: 989–994. Balestrieri B and Arm JP (2006). Group V sPLA2: classical and novel functions. Biochim. Biophys.

Acta. 1761: 1280–1288. Balint JA, Bondurant S, Kynakides EC (1971). Lecithin biosynthesis in cigarette smoking dogs. Arch

Intern Med. 127: 740–747. Batenburg JJ, Haagsman HP (1998). The lipids of pulmonary surfactant: dynamics and interactions with proteins. Prog Lipid Res 37: 235–276. Batenburg JJ, Ossendorp BC, Snoek GT, Wirtz KW, Houweling M, Elfring RH (1994). Phospholipid-transfer proteins and their mRNAs in developing rat lung and in alveolar type-II cells.

Biochem J 298: 223–229. Batenburg, J. J., and L. M. G. Van Golde. Formation of pulmonary surfactant in whole lung and in isolated type II alveolar cells. In: Reuiews in PerinatuZ Medicine, edited by E. M. Scarpelli and E. V. Cosmi, New York: Raven, 1979, vol. 3, p. 73-114. Beers MF, Hamvas A, Moxley MA, Gonzales LW, Guttentag SH, Solarin KO, Longmore WJ, Nogee LM, Ballard PL (2000). Pulmonary surfactant metabolism in infants lacking surfactant protein B. Am J Respir Cell Mol Biol. 22: 380-91. Birner R, Burgermeister M, Schneiter R, and Daum G (2001) Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae. Mol Biol Cell 12: 997–1007. Birner R, Nebauer R, Schneiter R, Daum G (2003) Synthetic lethal interaction of the mitochondrial phosphatidylethanolamine biosynthetic machinery with the prohibition complex of Saccharomyces cerevisiae. Mol Biol Cell 14: 370–383. Bligh EG, and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can J

Biochem Physiol. 37: 911–917. Bohlin K, Patterson BW, Spence KL, Merchak A, Zozobrado JC, Zimmermann LJ, Carnielli VP, Hamvas A (2005). Metabolic kinetics of pulmonary surfactant in newborn infants using exogenous stable isotope techniques. J. Lipid Res. 46: 1257–1265. Boumann HA, Gubbens J, Koorengevel MC, Oh CS, Martin CE, Heck AJ, Patton-Vogt J, Henry SA, de Kruijff B, de Kroon AI (2006) Depletion of phosphatidylcholine in yeast induces shortening and increased saturation of the lipid acyl chains: evidence for regulation of intrinsic membrane curvature in a eukaryote. Mol Biol Cell 17: 1006-1017. Bowton DL, Seeds MC, Fasano MB, et al (1997). Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit

Care Med.155: 421-425. Boyland E, Roe FJC, and Gorrod JW (1964). Induction of pulmonary tumours in mice by nitrosonornicotine, a possible constituent of tobacco smoke. Nature 202, 1126.

Bibliography

129

VN’s Lab, BDU

Boyland E, Roe FJC, Gorrod JW and Mitchley B C V (1964). The carcinogenicity of nitrosoanabasine, a possible constituent of tobacco smoke. Br. J. Cancer 18, 265-270. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254. Brasch F, Birzele J, Ochs M, Guttentag SH, Schoch OD, Boehler A, Beers MF, Müller KM, Hawgood S, Johnen G (2004).Surfactant proteins in pulmonary alveolar proteinosis in adults. Eur

Respir J. 24, 426-435. Bunt JE, Zimmermann LJ, Wattimena JL, van Beek RH, Sauer PJ, Carnielli VP (1998). Endogenous surfactant turnover in preterm infants measured with stable isotopes. Am. J. Resp. Crit.

Care Med. 157: 810–814. Burke JE, Dennis EA (2009). Phospholipase A2 structure/function, mechanism, and signaling. J.

Lipid Res. 50: 237–242. Burke JE, Dennis EA (2009). Phospholipase A2 biochemistry. Cardiovasc. Drugs Ther. 23: 49–59. Carman GM and Henry SA (2007) Phosphatidic acid plays a central role in the transcriptional

regulation of glycerophospholipid synthesis in Saccharomyces cerevisiae. J Biol Chem 282: 37293 – 37297. Carman GM and Zeimetz GM (1996) Regulation of phospholipid biosynthesis in the yeast Saccharomyces cerevisiae. J Biol Chem 271: 13293–13296. Carman GM, Henry SA (1999) Phospholipid biosynthesis in the yeast Saccharomyces cerevisiae and interrelationship with other metabolic processes. Prog Lipid Res 38: 361-399. Carman GM., and M.C. Kersting. 2004. Phospholipid synthesis in yeast: regulation by phosphorylation. Biochem Cell Biol. 82: 62–70. Chabot S, Koumanov K, Lambeau G, Gelb MH, Balloy V, Chignard M, Whitsett JA and Touqui L (2003). Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2. J. Immunol. 171: 995–1000. Chang Y, Edeen K, Lu X, De Leon M, Mason RJ (2006). Keratinocyte growth factor induces lipogenesis in alveolar type II cells through a sterol regulatory element binding protein-1c-dependent pathway. Am J Respir Cell Mol Biol. 35: 268–274. Chao W, Spragg RG and Smith RM. (1995). Inhibitory effect of porcine surfactant on the respiratory burst oxidase in human neutrophils. J. Clin. Invest. 96:2654–2660. Chen J, Higby R, Tian D, Tan D, Johnson MD, Xiao Y, Kellar KJ, Feng S, and Shields PG. 2008. Toxicological analysis of low-nicotine and nicotine-free cigarettes. Toxicology. 249: 194-203. Chen JW, Dodia C, Feinstein SI, Jain MK, Fisher AB (2000). 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem 275: 28421–28427. Chen X, Hyatt BA, Mucenski ML, Mason RJ, Shannon JM (2006). Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells. Proc Natl Acad Sci U S

A. 103: 11724–11729.

Bibliography

130

VN’s Lab, BDU

Chretien J, Grandordy B (1983). [Defense mechanisms of the respiratory system]. Schweiz Med Wochenschr Suppl 15: 36-42.

Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE, Whitsett JA (1995). Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc. Natl. Acad. Sci. U. S. A. 92: 7794–7798. Clements J: Dependence of pressure-volume characteristics of lungs on intrinsic surface- active material. Am J Physiol 1956; 187:592 Cook WA, Webb WR (1966). Surfactant in chronic smokers. Ann Thorac Surg. 2: 327-333. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER (1982). Cell number and cell characteristics of the normal human lung. Am. Rev. Respir. Dis. 126: 332-337. Creuwels LA, van Golde LM, Haagsman HP (1997). The pulmonary surfactant system: biochemical and clinical aspects. Lung 175:1-39. Cruz A, Worthman LA, Serrano AG, Casals C, Keough KM, Pérez-Gil J (2000). Microstructure and dynamic surface properties of surfactant protein SP-B/ dipalmitoylphosphatidylcholine interfacial films spread from lipid–protein bilayers. Eur. Biophys. J. 29: 204–213. Dahlqvist A, Stahl U, Lenman M, Banas A, Lee M, Sandager L, Ronne H, and Stymne S. 2000. Phospholipid: diacylglycerol acyltransferase: an enzyme that catalyzes the acyl-CoA-independent formation of triacylglycerol in yeast and plants. Proc Natl Acad Sci U S A. 97: 6487-6492. Das SK, Tsao FH, Mukherjee S (2002). Mainstream and sidestream cigarette smoke exposure increases Ca2+-dependent phospholipid binding proteins in guinea pig alveolar type II cells. Mol Cell Biochem. 231: 37-42. Davis PJ, Fleming BD, Coolbear KP, Keough KM (1981). Gel to liquid–crystalline transition temperatures of water dispersions of two pairs of positional isomers of unsaturated mixed-acid phosphatidylcholines. Biochemistry 20: 3633–3636. De Kroon AI (2007) Metabolism of phosphatidylcholine and its implications for lipid acyl chain composition in Saccharomyces cerevisiae. Biochim Biophys Acta 1771: 343-352. Den Breejen JN, Batenburg JJ, van Golde LM (1989). The species of acyl-CoA in subcellular fractions of type II cells isolated from adult rat lung and their incorporation into phosphatidic acid. Biochim Biophys Acta. 1002: 277–282. Dietl P, Haller T, Mair N, Frick M (2001). Mechanisms of surfactant exocytosis in alveolar type II cells in vitro and in vivo. News Physiol. Sci. 16: 239–243. Druckrey H, and Preussmann R (1962). Zur Entstehung carcinogener Nitrosamine am Beispiel des Tabakruachs. (The formation of carcinogenic nitrosamines in tobacco, as an example.) Die

Natur. 49, 488-499. Edelson JD, Vadas P, Villar J, Mullen JB, Pruzanski W (1991). Acute lung injury induced by phospholipase A2. Structural and functional changes. Am. Rev. Respir. Dis. 143: 1102–1109. Egberts J, Noort WA (1986). Gestational age-dependent changes in plasma inositol levels and surfactant composition in fetal rat. Pediat. Res. 20: 24-27.

Bibliography

131

VN’s Lab, BDU

Enhorning G, Duffy LC and Welliver RC (1995) Pulmonary surfactant maintains patency of conducting airways in the rat. Am J Respir Crit Care Med 151, 554-556. Enhorning G., Holm B.A (1998). Disruption of pulmonary surfactants ability to maintain openness of a narrow tube. J. Appl. Physiol, 74, 2922–2927. Exton JH, 1994. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta. 1212: 26-42. Ferreira T, Regnacq M, Alimardani P, Moreau-Vauzelle C, Berges T (2004) Lipid dynamics in yeast under haem-induced unsaturated fatty acid and/or sterol depletion. Biochem J 378: 899–908. Filgueiras OM, Possmayer F (1990). Purification and characterization of a phospholipase A2 associated with rabbit lung microsomes: some evidence for its mitochondrial origin.

Biochim Biophys Acta 1046: 258–266. Finley TN, Ladman AJ (1972). Low yield of pulmonary surfactant in cigarette smokers. N Engl J

Med 286: 223-227. Fisher AB, and Dodia C (1997). Role of acidic Ca2+- independent phospholipase A2 in synthesis of lung dipalmitoyl phosphatidylcholine. Am. J. Physiol. 272: 238–243. Fisher AB, Dodia C (2001). Lysosomal-type PLA2 and turnover of alveolar DPPC. Am J Physiol Lung

Cell Mol Physiol 280: L748–L754. Fisher AB, Dodia C, Chander A, Jain M (1992) A competitive inhibitor of phospholipase A2 decreases surfactant phosphatidylcholine degradation by the rat lung. Biochem J 288: 407–411. Fisher AB, Dodia C, Feinstein SI and Ho YS (2005). Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2. J. Lipid Res. 46: 1248–1256. Flieger A, Gongab S, Faigle M, Mayer HA, Kehrer U, Mussotter J, Bartmann P and Neumeister B. (2000). Phospholipase A secreted by Legionella pneumophila destroys alveolar surfactant phospholipids. FEMS Microbiol. Lett. 188: 129–133. Foiles PG, Akerkar SA, Carmella SG, Kagan M, Stoner GD, Resau JH, Hecht SS. (1991). Chem. Res.

Toxico. 4: 364-368. Foiles PG, Akerkar SA, Carmella SG, Kagan M, Stoner GD, Resau JH, Hecht SS. (1991). Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and non-smokers. Chem. Res. Toxico. 4: 364-368. Foster CD, Zhang PX, Gonzales LW, Guttentag SH (2003). In vitro surfactant protein B deficiency inhibits lamellar body formation. Am. J. Respir. Cell. Mol. Biol. 29: 259–266. Funkhouser JD, Batenburg JJ and Van Golde LM (1981). Acylation of 1-palmitoyl-lysophosphatidylglycerol in a alveolar type II cells from rat lung.Biochim. Biophys. Acta. 666: 1–6 Fyrst H, Oskouian B, Kuypers FA and Saba JD. (1999) The PLB2 gene of Saccharomyces cerevisiae confers resistance to lysophosphatidylcholine and encodes a phospholipase B/lysophospholipase. Biochemistry 38, 5864–5871.

Bibliography

132

VN’s Lab, BDU

Gaspar ML, Jesch SA, Viswanatha R, Antosh AL, Brown WJ, Kohlwein SD, Henry SA (2008) A block in endoplasmic reticulum-to-Golgi trafficking inhibits phospholipid synthesis and induces neutral lipid accumulation. J Biol Chem 283: 25735-25751. Gheriani-Gruszka NS, Almog RL, Biltonen and Lichtenberg D 1988. Hydrolysis of phosphatidylcholine in phosphatidylcholine-cholate mixtures by porcine pancreatic phospholipase A2. J Biol Chem. 263: 11808 –11813. Ghosh AK, Ramakrishnan G and Rajasekharan R, 2008. YLR099C (ICT1) encodes a soluble Acyl-CoA-dependent lysophosphatidic acid acyltransferase responsible for enhanced phospholipid synthesis on organic solvent stress in Saccharomyces cerevisiae. J Biol Chem. 283: 9768-75. Giammona ST, Tocci P, Webb WR (1971). Effects of cigarette smoke on incorporation of radioisotopically labeled palmitic acid into pulmonary surfactant and on surface activity of canine lung extracts. Am Rev Respir Dis 104:358–367. Goerke J (1998). Pulmonary surfactant: functions and molecular composition. Biochim Biophys

Acta 1408: 79-89. Gonzalez R, Yang YH, Griffin C, Allen L, Tigue Z, Dobbs L (2005). Freshly isolated rat alveolar type I cells, type II cells, and cultured type II cells have distinct molecular phenotypes. Am J

Physiol Lung Cell Mol Physiol 288: L179–L189. Greenberger PA (1997). Immunologic aspects of lung diseases and cystic fibrosis. JAMA 278: 1924-1930. Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA 3rd, Hudson LD, Maunder RJ, Crim C, Hyers TM (1991). Surfactant chemical composition and biophysical activity in Acute Respiratory Distress Syndrome. J. Clin. Invest. 88: 1976–1981. Griese M (1999). Pulmonary surfactant in health and human lung diseases: state of the art. Eur

Respir J. 13: 1455-76. Griese M, Birrer P and Demirsoy A (1997). Pulmonary surfactant in cystic fibrosis. Eur. Respir. J. 10: 1983–1988. Günther A, Walmrath D, Grimminger F, Seeger W (2001). Pathophysiology of acute lung injury.

Semin. Respir. Crit. Care Med. 22: 247–258. Guerin MR, Jenkins RA, Tomkins BA (1992). The chemistry of environmental tobacco smoke: Composition and measurement. Lewis Publishers, Boca Raton. Gunther A, Ruppert C, Schmidt R, et al (2001). Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res. 2: 353–364. Gupta PC and Ray CC (2003). Smokeless tobacco and health in India and South Asia. Respirology, 8, 419–431. Gurel O, Ikegami M, Choroneos ZC, Jobe AH (2001). Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L1266–72. Guthmann F, Harrach-Ruprecht B, Looman AC, Stevens PA, Robenek H, Rustow B (1997). Interaction of lipoproteins with type II pneumocytes in vitro: morphological studies, uptake kinetics and secretion rate of cholesterol. Eur J Cell Biol 74: 197–207.

Bibliography

133

VN’s Lab, BDU

Haagsman HP (1992). Toxicological aspects of the surfactant system. In: Robertson B, van Golde L, Batenburg JJ, eds. Pulmonary surfactant: from molecular biology to clinical practice. Amsterdam, Elsevier. 705-734. Hallman M, Gluck L (1980). Formation of acidic phospholipids in rabbit lung during perinatal development. Pediatr. Res. 14:1250-1259. Hallman M, Kulovich M, Kirkpatrick E, Sugarman RG, Gluck L (1976). Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am. J. Obstet. Gynecol. 125: 613-617. Hallman M, Spragg R, Harrell JH, Moser KM, Gluck L (1982). Evidence of lung surfactant abnormality in respiratory failure. J Clin Invest. 70: 673–683. Hamm H, Fabel H, Bartsch W (1992). The surfactant system of the adult lung: physiology and clinical perspectives. Clin-Investig. 70: 637-57. Han WK, Sapirstein A, Hung CC, Alessandrini A, Bonventre JV (2003). Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid release. J. Biol.

Chem. 278: 24153–24163. Hanasaki K, Ono T, Saiga A, Morioka Y, Ikeda M, Kawamoto K, Higashino K, Nakano K, Yamada K, Ishizaki J, Arita H (1999). Purified group X secretory phospholipase A(2) induced prominent release of arachidonic acid from human myeloid leukemia cells. J. Biol. Chem. 274: 34203–34211. Harwood JL, Richards RJ (1985). Lung Surfactant. Mol Aspects Med 8: 423-514. Hatherill JR, Stephens KE, Nagao K, Ishizaka A, Wilmarth L, Wang JC, Deinhart T, Larrick JW, Raffin TA (1989). Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release. J. Biol. Response

Mod 8: 614–624. Hawco MW, Davis PJ, Keough KM (1981). Lipid fluidity in lung surfactant: monolayers of saturated and unsaturated lecithins. J. Appl. Physiol. 51: 509–515. Hawgood S, Efrati H, Schilling J, Benson BJ (1985). Chemical characterization of lung surfactant apoproteins: amino acid composition, N-terminal sequence and enzymic digestion.

Biochem Soc Trans. 13: 1092-1096. Hecht SS (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines.

Chem Res Toxicol. 11, 559-603. Hecht SS (1999).Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 91: 1194-1210. Hecht SS (2003). Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat. Rev.

Cancer, 3, 733–744 Hecht SS and Hoffmann D (1988). Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9, 875-884. Hecht SS and Hoffmann D (1989). The relevance of tobaccospecific nitrosamines to human cancer.

Cancer Surv. 8, 273-294.

Bibliography

134

VN’s Lab, BDU

Hecht SS, and Hoffmann D (1988). Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis. 9: 875-884. Henry SA, and Patton-Vogt JL (1998). Genetic regulation of phospholipid metabolism: yeast as a model eukaryote. Prog. Nucleic Acid Res. Mol. Biol.61, 133–179. Hidi R, Vial D, Havet N, Berger A, Vargaftig BB, Touqui L (1997). Inhibition by pulmonary surfactant Curosurf of secretory phospholipase A2 expression in guinea-pig alveolar macrophages. Biochem Pharmacol.54: 1055–1058. Hirabayashi T, Murayama T, Shimizu T (2004). Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol. Pharm. Bull. 27: 1168–1173. Hiraoka M, Abe A, Lu Y, Yang K, Han X, Gross RW and Shayman JA (2006). Lysosomal phospholipase A2 and phospholipidosis. Mol. Cell. Biol. 26: 6139–6148. Hirasawa N, Santini F, Beaven MA (1995). Activation of the mitogen-activated protein kinase/cytosolic phospholipase A2 pathway in a rat mast cell line. Indications of different pathways for release of arachidonic acid and secretory granules. J. Immunol. 154: 5391–5402. Hirche TO, Crouch EC, Espinola M, et al (2004). Neutrophil Serine Proteinases Inactivate Surfactant Protein D by Cleaving within a Conserved Subregion of the Carbohydrate Recognition Domain. J Biol Chem. 279: 27688-27698. Hite RD, Seeds MC, Bowton DL, Grier BL, Safta AM, Balkrishnan R, Waite BM, Bass DA (2005). Surfactant phospholipid changes after antigen challenge: a role for phosphatidylglycerol in dysfunction. Am J Physiol Lung Cell Mol Physiol. 288: 610-617. Hite RD, Seeds MC, Jacinto RB, Balasubramanian R, Waite M, Bass D (1998). Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2.

Am. J. Physiol. 275: L740–L747. Hite RD, Seeds MC, Jacinto RB, et al (2005). Lysophospholipid and fatty acid inhibition of pulmonary surfactant: non-enzymatic models of phospholipase A2 surfactant hydrolysis.

Biochim Biophys Acta.1720:14 -21. Hite RD, Seeds MC, Safta AM, et al (2005). Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A(2)-mediated surfactant dysfunction. Am J Physiol Lung Cell

Mol Physiol. 288: 618-624. Hoffman D, Djordjevic M and Hoffman I (1997). The changing cigarette. Prev Med 26, 427-434. Hoffmann D and Hecht SS (1985). Nicotine-derived N-nitrosamines and tobacco related cancer: current status and future directions. Cancer Res. 45, 935-944. Hoffmann D and Hecht SS (1990). Advances in tobacco carcinogenesis. In Handbook of

Experimental Pharmacology (Cooper, C. S., and Grover, P. L., Eds.) pp 63-102, Springer- Verlag, Heidelberg. Hoffmann D, Brunnemann KD, Prokopczyk B and Djordjevic MV (1994). Tobacco-specific N-nitrosamines and arecaderived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health 41, 1-52. Hoffmann D, Hecht SS, Ornaf, RM, and Wynder, EL (1974). N’-nitrosonornicotine in tobacco. Science 186, 265-267.

Bibliography

135

VN’s Lab, BDU

Hoffmann D, Rathkamp G, and Liu YY (1974). On the isolation and identification of volatile and nonvolatile N-nitrosamines and hydrazines in cigarette smoke. N-Nitroso Compounds in the Environment, IARC Scientific Publ. No. 9, pp 159-165, International Agency for Research on Cancer, Lyon, France. Hohlfeld J, Fabel H, Hamm H (1997). The role of pulmonary surfactant in obstructive airways disease. Eur Respir J. 10: 482-491. Hohlfeld JM (2003). Pulmonary surfactant and liquid equilibrium in the lung. In Gibson J et al Respiratory Medicine, 3ed, (Saunders WB Ltd, eds, a division of Elsevier Science) 93-104. Holm BA, Keicher L, Liu MY, et al (1991). Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol. 71: 317-321. Homer RJ, Zheng T, Chupp G, He S, Zhu Z, Chen Q, Ma B, Hite RD, Gobran LI, Rooney SA, Elias JA (2002). Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol 283: L52–L59. Hughes DA, Haslam PL (1990). Effect of smoking on the lipid composition of lung lining fluid and relationship between immunostimulatory lipids, inflammatory cells and foamy macrophages in extrinsic allergic alveolitis. Eur Respir J 3: 1128- 1139. Hunninghake GW, Crystal RG (1983). Cigarette smoking and lung destruction. Am Rev Respir Dis. 128: 833–838. Hurley BP, McCormick BA(2008).Multiple roles of phospholipase A2 during lung infection and inflammation.Infect Immun, 76, 2259-2272. IARC Monogr (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines; Eval Carcinog Risks Hum, 89 1-592. Inoue S, Kogaki H, Ikeda K, Samejima Y, Omori-Satoh T (1991). Amino acid sequences of the two subunits of a phospholipase A2 inhibitor from the blood plasma of Trimeresurus flavoridis. Sequence homologies with pulmonary surfactant apoprotein and animal lectins. J. Biol.

Chem. 266: 1001–1007. International Agency for Research on Cancer (1985). Tobacco habits other than smoking: betel quid and areca nut chewing and some related nitrosamines. IARC Monographs on the

Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37, International Agency for Research on Cancer, Lyon, France. International Agency for Research on Cancer (1986). Tobacco smoking. IARC Monographs on

the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, International Agency for Research on Cancer, Lyon, France. Iribarren C, Jacobs DR Jr, Sidney S, Gross MD, Eisner MD (2000). Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest. 117: 163-168. Jacobs H, Jobe A, Ikegami M, Jones S (1982). Surfactant phosphatidylcholine source, fluxes, and turnover times in 3-day-old, 10-day-old, and adult rabbits. J. Biol. Chem. 257: 1805–10. Jha P, Jacob B, Gajalakshmi V, Gupta PC, Dhingra N, Kumar R, Sinha DN, Dikshit RP, Parida DK, Kamadod R, Boreham J, Peto R; RGI-CGHR Investigators (2008). A nationally representative case-control study of smoking and death in India. N Engl J Med, 358, 1137-1147.

Bibliography

136

VN’s Lab, BDU

Jobe A.H., Lung Development and Maturation, Neonatal–Perinatal Medicine, Mosby, St. Louis, 2002. Johnson MD, Bao HF, Helms MN, Chen XJ, Tigue Z, Jain L, Dobbs LG, Eaton DC (2006). Functional ion channels in pulmonary alveolar type I cells support a role for type I cells in lung ion transport. Proc Natl Acad Sci USA 103: 4964–4969. Juresic GC, Blagovic B, Rupcic J (2009) Alterations in Phosphatidylcholine and Phosphatidylethanolamine Content During Fermentative Metabolism in Saccharomyces

cerevisiae Brewer’s Yeast; Food Technol. Biotechnol, 47 246–252. Karagiorga G, Nakos G, Galiatsou E, Lekka ME (2006). Biochemical parameters of bronchoalveolar lavage fluid in fat embolism. Intensive Care Med. 32: 116–123. Kikawada E, Bonventre JV, Arm JP (2007). Group V secretory PLA2 regulates TLR2- dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2 alpha activation. Blood 110: 561–567. Kinney AJ, Carman GM (1988). Phosphorylation of yeast phosphatidylserine synthase in vivo and in vitro by cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 85: 7962–7966. Kitsiouli E, Nakos G, Lekka ME (2009). Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta. 1792 : 941-953. Kogaki H, Inoue S, Ikeda K, Samejima Y, Omori-Satoh T, Hamaguchi K (1989). Isolation and fundamental properties of a phospholipase A2 inhibitor from the blood plasma of

Trimeresurus flavoridis. J. Biochem. 106: 966–971. Kostopanagiotou GG, Kalimeris KA, Arkadopoulos NP, Pafiti A, Panagopoulos D, Smyrniotis V, Vlahakos D, Routsi C, Lekka ME, Nakos G (2009). Desferrioxamine attenuates minor lung injury following surgical acute liver failure. Eur. Respir. J. 33: 1429–1436. Kremlev SG, Unstead TM and Phelps DS (1994). Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am. J.

Kruijff BD (2006) Membranes, where lipids and proteins meet. Chem Phys Lipids 143: 41–42. Kuroki Y, Mason RJ, Voelker D (1988). Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J Biol Chem 263: 3388-3394. Kuroki Y, Voelker DR (1994). Pulmonary surfactant proteins. J. Biol. Chem. 269: 25943–25946. Kuronuma K, Mitsuzawa H, Takeda K, Nishitani C, Chan ED, Kuroki Y, Nakamura M, Voelker DR (2009). Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem 284: 25488–25500. Kwatia MA, Doyle CB, Cho W, et al (2007). Combined activities of secretory phospholipases and eosinophil lysophospholipases induce pulmonary surfactant dysfunction by phospholipid hydrolysis. J Allergy Clin Immunol.119: 838-847. Lands WE (1958). Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. J. Biol. Chem. 231 : 883 – 888 .

Bibliography

137

VN’s Lab, BDU

Lands, W.E.M. and Crawford, C.G. (1976) Enzymes of membrane phospholipid metabolism in animals in The Enzymes of Biological Membranes (Martonosi, A., ed.) Vol. 2, pp. 3–85, Plenum Press, New York Lannan S, Donaldson K, Brown D, MacNee W (1994). Effect of cigarette smoke and its condensates on alveolar epithelial cell injury in vitro. Am J Physiol 266: L92-100. Lauren Kent, Lucy Smyth, Chris Clayton, Laurie Scott, Ted Cook, Richard Stephens, Steve Fox, Peter Hext, Stuart Farrow, Dave Singh (2008). Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine 42, 205–216. Lazarov S, Yanev E, Momchilova A, Markovska T, Ivanova L, Pankov R. (2007). Alterations of the composition and metabolism of pulmonary surfactant phospholipids induced by experimental peritonitis in rats. Chem Biol Interact. 169: 73-79. Le Mesurier SM, Stewart BW, Lykke AW (1981). Injury to type-2 pneumocytes in rats exposed to cigarette smoke. Environ Res. 24: 207–217. Lee KS, Patton JL, Fido M, Hines LK, Kohlwein SD, Paltauf F, Henry SA, Levin DE (1994). The Saccharomyces cerevisiae PLB1 gene encodes a protein required for lysophospholipase and phospholipase B activity. J Biol Chem.269:19725-19730. Lekka ME, Liokatis S, Nathanail C, Galani V, Nakos G (2004). The impact of intravenous fat emulsion administration in acute lung injury. Am. J. Respir. Crit. Care Med. 169: 638–644. LeVine AM, Lotze A, Stanley C, Stroud O’Donnell R, Whitsett J and Pollack MM (1996). Surfactant content in children with inflammatory lung disease. Crit. Care Med. 24:1062–1067. Lewis JF, Jobe AH (1993). Surfactant and the adult respiratory distress syndrome. Am Rev Respir

Dis. 147: 218–233. Lin RK, Hsieh YS, Lin P, Hsu HS, Chen CY, Tang YA, Lee CF and Wang YC (2010). The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. Journal of Clinical

Investigation .120 : 521 - 532. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ (1993). cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278. Lindbom J, Ljungman AG, Lindahl M, Tagesson C (2001). Expression of members of the phospholipase A2 family of enzymes in human nasal mucosa. Eur. Respir. J. 18:130–138. Lindbom J, Ljungman AG, Lindahl M, Tagesson C (2002). Increased gene expression of novel cytosolic and secretory phospholipase A(2) types in human airway epithelial cells induced by tumor necrosis factor-alpha and IFN-gamma. J. Interferon Cytokine Res. 22: 947–955. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, eds. Global burden of disease and risk factors, New York and Washington. New York: Oxford University Press, 2006. Low RB, Davis GS, Giancola MS (1978). Biochemical analyses of bronchoalveolar lavage fluids of healthy human volunteer smokers and nonsmokers. Am Rev Respir Dis 118: 863-875. Malanovic N, Streith I, Wolinski H, Rechberger G, Kohlwein SD, Tehlivets O (2008) S-adenosyl-L-homocysteine hydrolase, key enzyme of methylation metabolism, regulates phosphatidylcholine synthesis and TAG homeostasis in yeast: implications for homocysteine as a risk factor of atherosclerosis. J Biol Chem 283: 23989-23999.

Bibliography

138

VN’s Lab, BDU

Mancini NM, Bene MC, Gerard H, Chabot F, Faure G, Polu JM, Lesur O (1993). Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids. Lung 171: 277-291. Marinetti GV, Erbland J, Albrecht M and Elmer Stotz (1958). Time study of incorporation in vivo of 32P-orthophosphate into phosphatides of rat tissues. Biochimica et Biophysica Acta. 30, 543-548. Mason RJ, Nellenbogen J (1984). Synthesis of saturated phosphatidylcholine and phosphatidylglycerol by freshly isolated rat alveolar type II cells. Biochim Biophys Acta. 794: 392–402. Mason RJ, Pan T, Edeen KE, Nielsen LD, Zhang F, Longphre M, Eckart MR, Neben S (2003). Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells. J Clin Invest 112: 244–255. Mason RJ, Voelker DR (1998). Regulatory mechanisms of surfactant secretion. Biochim. Biophys.

Acta 1408: 226 - 40. Masuda S, Murakami M, Mitsuishi M, Komiyama K, Ishikawa Y, Ishii T and Kudo I (2005). Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandinsynthetic function in human lung-derived cells. Biochem.

J. 387: 27–38. Matute-Bello G,Liles W, Radella F (1997). Neutrophil apoptosis in the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 156: 1969–1977. Mayr JA, Kohlwein SD, Paltauf F (1996). Identification of a novel, Ca(2+)-dependent phospholipase D with preference for phosphatidylserine and phosphatidylethanolamine in Saccharomyces cerevisiae. FEBS Lett. 393:236-240. McCormack FX (1998). Structure, processing and properties of surfactant protein A. Biochim

Biophys Acta. 1408: 109-31. Medjane S, Raymond B, Wu Y and Touqui L (2005). Impact of CFTR DeltaF508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells. Am J Physiol Lung Cell Mol. Physiol. 289: 816–824. Melton KR, Nesslein LL, Ikegami M, Tichelaar JW, Clark JC, Whitsett JA, Weaver TE (2003). SP-B deficiency causes respiratory failure in adult mice. Am. J. Physiol. Lung Cell Mol. Physiol. 285 L543–549. Merkel O, Oskolkova OV, Raab F, El-Toukhy R, Paltauf F (2005) Regulation of activity in vitro and in vivo of three phospholipases B from Saccharomyces cerevisiae. Biochem J 387: 489-496. Miles PR, Ma JY, Bowman L (1988). Degradation of pulmonary surfactant disaturated phosphatidylcholines by alveolar macrophages. J. Appl. Physiol. 64: 2474–81. Miller D, Bondurant S (1962). Effects of cigarette smoke on the surface characteristics of lung extracts. Am Rev Respir Dis. 85: 692-696. Morrison WR, Smith LM (1964) Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoridemethanol. J Lipid Res 5: 600–608. Murakami M and Kudo I (2004). Secretory phospholipase A2. Biol. Pharm. Bull. 27: 1158–1164.

Bibliography

139

VN’s Lab, BDU

Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I (1997). Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17: 225–283. Murakami M, Shimbara S, Kambe T, Kuwata H, Winstead MV, Tischfield JA, Kudo I (1998). The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2s are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem. 273: 14411–14423. Nachiappan V, Mufti SI, Chakravarti A, Eskelson CD, Rajasekharan R (1994) Lipid peroxidation and ethanol-related tumor promotion in Fischer-344 rats treated with tobacco-specific nitrosamines. Alcohol Alcohol 29: 565-574. Nagase TN, Uozumi S, Ishii K, Kume T, Izumi Y, Ouchi and T. Shimizu (2000). Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2. Nat. Immunol. 1: 42–46. Nair J, Pakhale SS and Bhide SV (1989). Carcinogenic tobacco-specific nitrosamines in Indian tobacco products. Food chem. Toxicol, 27, 751–753. Nakos G, Kitsiouli EI, Lekka ME (1998). Bronchoalveolar lavage alterations in pulmonary embolism. Am. J. Respir. Crit. Care Med. 158: 1504–1510. Nakos G, Kitsiouli EI, Tsangaris I, Lekka ME (1998). Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components. Intensive Care Med. 24: 296–303. Ni Z, Okeley NM, Smart BP, Gelb MH (2006). Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells. J. Biol. Chem. 281: 16245–16255. Nieman GF, Clark WR, Wax SD and Webb SR (1980). The effect of smoke inhalation on pulmonary surfactant. Ann Surg, 191, 171–181. Nogee LM (2002). Abnormal expression of surfactant protein C and lung disease. Am J Respir Cell

Mol Biol. 26,641-644. Nogee LM (2004). Alterations in SP-B and SP-C expression in neonatal lung disease. Annu. Rev.

Physiol. 66: 601–623. Numata M, Chu HW, Dakhama A, Voelker DR (2010). Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc Natl Acad Sci

USA 107: 320–325. Obladen M., History of surfactant research, in: L.M.G. van Golde, J.J. Batenburg (Eds.), Pulmonary Surfactant: From Molecular Biology to Clinical Practice, Elsevier Science, Amsterdam, 1992, pp. 1–18. Ockene IS, Miller NH (1997). Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation. 96: 3243-3247. Ohtsuki M, Taketomi Y, Arata S, Masuda S, Ishikawa Y, Ishii T, Takanezawa Y, Aoki J, Arai H, Yamamoto K, Kudo I, Murakami M (2006). Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J. Biol. Chem. 281: 36420–36433.

Bibliography

140

VN’s Lab, BDU

Okamoto K, Kim JS and Rubin BK (2007). Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea. Am J Physiol Lung Cel Mol Physiol. 292: 62–67. Orgeig S, Daniels CB (2001). The roles of cholesterol in pulmonary surfactant: insights from comparative and evolutionary studies. Comp Biochem Physiol A Mol Integr Physiol 129: 75-89. Orgeig S, Daniels CB, Johnston SD, Sullivan LC (2003). The pattern of surfactant cholesterol during vertebrate evolution and development: does ontogeny recapitulate phylogeny? Reprod

Fertil Dev 15: 55-73. Oulton M, Moores HK, Scott JE, Janigan DT, and Hajela R. 1991. Effects of Smoke Inhalation on Surfactant Phospholipids and Phospholipase A2 Activity in the Mouse Lung. Am. J. Pathol. 138: 195-202. Oulton MR, Janigan DT, MacDonald JM, Faulkner GT, Scott JE (1994). Effects of smoke inhalation on alveolar surfactant subtypes in mice. Am J Pathol, 145, 941-50. Pattle RE (1955). Properties, function and origin of the alveolar lining layer. Nature 175: 1125-1126. Pérez R, Melero R, Balboa MA, Balsinde J (2004). Role of group VIA calciumindependent phospholipase A2 in arachidonic acid release, phospholipid fatty acid incorporation, and apoptosis in U937 cells responding to hydrogen peroxid. J. Biol. Chem. 279: 40385–40391.

Physiol. 267: 357–364. Perez-Chacon G, Astudillo AM, Balgoma D, Balboa MA, Balsinde J (2009). Control of free arachidonic acid levels by phospholipases A2 and lysophospholipid acyltransferases.

Biochim Biophys Acta. 1791, 1103-1113. Pérez-Gil J, Keough KM (1998). Interfacial properties of surfactant proteins. Biochim. Biophys. Acta 1408: 203–217. Perez-Gil J, Weaver TE (2010). Pulmonary surfactant pathophysiology: current models and open questions. Physiology (Bethesda) 25:132-41. Perisic O, Fong S, Lynch DE, Bycroft M, Williams RL (1998). Crystal structure of a calcium-phospholipid binding domain from cytosolic phospholipase A2. J. Biol. Chem. 273: 1596–1604. Pison U, Herold R, Schürch S (1996). The pulmonary surfactant system: biological functions, components, physicochemical properties and alterations during lung disease. Colloids and

Surfaces. A, Physicochemical and Engineering Aspects. 114, 165–184. Preussmann R, Stewart B (1984). Chemical Carcinogens. 2nd ed. Vol 2. ACS Monograph 182. Searle CE (ed) Washington, DC: American Chemical Society, pp. 643-828. Rahman I, Li XY, Donaldson K, Harrison DJ, MacNee W (1995). Glutathione homeostasis in alveolar epithelial cells in vitro and lung in vivo under oxidative stress. Am J Physiol 269: L285-292. Rajakumari S, Grillitsch K, and Daum G. 2008. Synthesis and turnover of non-polar lipids in yeast.

Prog Lipid Res. 47: 157–171.

Bibliography

141

VN’s Lab, BDU

Rau G, Dombrowsky H, Gebert A, Thole H, von Hardt H, Freihorst J, Bernhard W (2003). Phosphatidylcholine metabolism of rat trachea in relation to lung parenchyma and surfactan. J. Appl. Physiol. 95: 1145–1152. Rice WR, Ross GF, Singleton FM, Dingle S, Whitsett JA (1987). Surfactant-associated protein inhibits phospholipid secretion from type II cells. J Appl Physiol 63: 692- 698. Rima Mendonsa, JoAnne Engebrecht (2009). Phospholipase D function in Saccharomyces cerevisiae. Biochimica et Biophysica Acta 1791; 970–974. Robert F, Jeanine DA (2006).The effect of cigarette smoke–derived oxidants on the inflammatory response of the lung. Clinical and Applied Immunology Reviews 6, 53–72 Rodriguez-Capote K, Nag K, Schurch S, Possmayer F (2001). Surfactant protein interactions with neutral and acidic phospholipid films. Am J Physiol Lung Cell Mol Physiol 281: L231- 242. Ross M, Krol S, Janshoff A, Galla HJ (2002). Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C. Eur. Biophys. J. 31: 52-61. Ryan RM, Morris RE, Rice WR, Ciraolo G, Whitsett J (1989). Binding and uptake of pulmonary surfactant protein (SP-A) by pulmonary type II epithelial cells. J Histochem Cytochem 37: 429-440. Saiga A, Uozumi N, Ono T, Seno K, Ishimoto Y, Arita H, Shimizu T and Hanasaki K (2005). Group X secretory phospholipase A2 can induce arachidonic acid release and eicosanoid production without activation of cytosolic phospholipase A2 . Prostaglandins Other Lipid

Mediat. 75: 79–89. Sanford GL and Frosolono MF (1983). The role of acyl transferase in the biosynthesis of pulmonary microsomal phosphatidylglycerol. Biochem. Biophys. Res. Commun.116: 23–29

Sano H and Kuroki Y (2005). The lung collectins, SP-A and SP-D, modulate pulmonary innate immunity. Mol. Immunol. 42: 279–287. Sauk JJ, Norris K (1988) Tobacco components induce alterations in keratinocyte lipid membrane fluidity and inhibit cell proliferation in culture. J Oral Pathol 17: 30-33. Schaloske RH and Dennis EA (2006). The phospholipase A2 superfam- ily and its group numbering system. Biochim. Biophys. Acta 1761: 1246–1259. Schlame M, Kelley RI, Feigenbaum A, Towbin JA, Heerdt PM, Schieble T, Wanders RJ, DiMauro S, Blanck TJ (2003). Phospholipid abnormalities in children with Barth syndrome. J Am Coll

Cardiol. 42: 1994-1999. Schmekel B, Bos JA, Khan AR, Wohlfart B, Lachmann B, Wollmer P (1992). Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. Thorax 47: 603-608. Schmekel B, Khan AR, Linden M, Wollmer P (1991). Recoveries of phosphatidylcholine and alveolar macrophages in lung lavage from healthy light smokers. Clin Physiol 11: 431-438. Schmid B, Finne MJ, Harwood JL, Jackson SK (2003). Acylation of lysophosphatidylcholine plays a key role in the response of monocytes to lipopolysaccharide. Eur. J. Biochem. 270: 2728–2788. Schmidt R, Meier U, Yabut-Perez M, Walmrath D, Grimminger F, Seeger W, Günther A (2001). Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute

Bibliography

142

VN’s Lab, BDU

respiratory distress syndrome and severe pneumonia. Am J Respir Crit Care Med. 163: 95-100. Schmitz G, Muller G (1991). Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 32: 1539–1570. Schuster GS, Caughman GB and Dirksen TR (1995). Alteration of epithelial cell lipid synthesis by N-nitrosonornicotine. In Vitro Cell Dev Bio - Anim. 31: 295-299. Schuster GS, Erblad JF, Wyrick SD Singh BB (1986) Oral epithelial cell lipid synthesis in the presence of retinoic acid or nitrosonornicotine. J Oral Pathol 15: 430-433. Schuster GS, Lubas S, Dirksen TR, Erbland JF (1992) Lipids as factors in the cell response to tobacco components Natl Cancer Inst Monogr 2: 191-201. Schuster GS, Lubas S, Erbland JF, Singh BB (1990) Binding and uptake of N-nitrosonornicotine by oral epithelial cells. J Oral Pathol Med 19: 114-118. Schweizer M. (2004). Lipids and membranes. In The Metabolism and Molecular Physiology of Saccharomyces cerevisiae, J.R. Dickinson, and M. Schweizer, eds. (London, NY, Washington D.C.: CRC Press), pp. 140-223. Scott JE. 2004. The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung Development. Tob Induc Dis. 2: 3-25. Seeds MC, Bowton DL, Hite RD, et al (2003). Human eosinophil group IID secretory phospholipase A2 causes surfactant dysfunction. Chest 123: 3765-3775. Seeds MC, Jones KA, Duncan Hite R, Willingham MC, Borgerink HM, Woodruff RD, Bowton DL, Bass DA (2000). Cell-specific expression of group X and group V secretory phospholipases A(2) in human lung airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 23: 37–44. Selig WM, Durham SK, Welton AF (1989). Pulmonary responses to phospholipase A2 in the perfused guinea pig lung. J. Appl. Physiol. 67: 2495–2503. Serhan CN (2007). Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 25: 101–137. Serrano AG, Ryan M, Weaver TE, Pérez-Gil J (2006). Critical structure–function determinants within the N-terminal region of pulmonary surfactant protein SP-B, Biophys. J. 90: 238–249. Shalimov SA, Rededochovsky AP, Keysevich LB, Manual of Experimental Surgery, Medicina, Moscow, 1989. Shannon JM, Pan T, Nielsen LD, Edeen KE, Mason RJ (2001). Lung Fibroblasts Improve Differentiation of Rat Type II Cells in Primary Culture. Am J Respir Cell Mol Biol. 24: 235–244. Sharp JD, Pickard RT, Chiou XG, Manetta JV, Kovacevic S, Miller JR, Varshavsky AD, Roberts EF, Strifler BA, Brems DN, Kramer RM (1994). Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2. J. Biol. Chem. 269: 23250–23254. Sigrist H, Sigrist-Nelson K, Gitler C (1977). Single-phase butanol extraction: a new tool for proteolipid isolation. Biochem Biophys Res Commun. 74:178-184.

Bibliography

143

VN’s Lab, BDU

Sippola T, Aho H, Peuravuori H, Lukkarinen H, Gunn J, Kääpä P (2006). Pancreatic phospholipase A2 contributes to lung injury in experimental meconium aspiration. Pediatr. Res. 59: 641–645. Six DA, Dennis EA (2000). The expanding superfamily of phospholipase A2 enzymes: classification and characterization. Biochim. Biophys. Acta 1488: 1–19. Spiegelhalder B and Bartsch H (1996). Tobacco-specific nitrosamines. Eur. J. Cancer Prev. 5, 33-38. Stahlman MT, Gray MP, Falconieri MW, Whitsett JA, Weaver TE (2000). Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab. Invest. 80: 395–403. Stepanov I, Hecht SS, Ramakrishnan S and Gupta PC (2005). Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int. J. Cancer, 116, 16–19 Stinn W, Arts JH, Buettner A, Duistermaat E, Janssens K, Kuper CF, and Haussmann HJ (2010). Murine lung tumor response after exposure to cigarette mainstream smoke or its particulate and gas/vapor phase fractions. Toxicology. 275: 10-20 Storey MK, Clay KL, Kutateladze T, Murphy RC, Overduin M, and Voelker DR (2001) Phosphatidylethanolamine has an essential role in Saccharomyces cerevisiae that is independent of its ability to form hexagonal phase structures. J Biol Chem 276: 48539–48548. Subramaniam S, Bummer P, Gairola CG (1995). Biochemical and biophysical characterization of pulmonary surfactant in rats exposed chronically to cigarette smoke. Fundam Appl Toxicol 27: 63-69. Subramaniam S, Whitsett JA, Hull W, Gairola CG (1996). Alteration of pulmonary surfactant proteins in rats chronically exposed to cigarette smoke. Toxicol Appl Pharmacol 140: 274-280. Takamoto DY, Lipp MM, von Nahmen A, Lee KY, Waring AJ, Zasadzinski JA (2001). Interaction of lung surfactant proteins with anionic phospholipids. Biophys J 81: 153-169. Tehlivets O, Scheuringer K, Kohlwein SD (2007) Fatty acid synthesis and elongation in yeast. Biochim Biophys Acta 1771: 255–270. Thomson NC, Chaudhuri R, Livingston E (2004). Asthma and cigarette smoking. Eur Respir J. 24: 822–833. Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, Tetley TD (2007). Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol 178: 463–473. Tolle A, Meier W, Rudiger M, Hofmann KP, Rustow B (2002). Effect of cholesterol and surfactant protein B on the viscosity of phospholipid mixtures. Chem Phys Lipids 114: 159-168. Tonstad S and Johnston J A (2006). Cardiovascular risks associated with smoking: a review for clinicians. European Journal of Cardiovascular Prevention and Rehabilitation. 13: 507 - 514. Touqui L, Alaoui-El-Azher M (2001). Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med. 1: 739–754.

Bibliography

144

VN’s Lab, BDU

Touqui L, Arbibe L (1999). A role for phospholipase A2 in ARDS pathogenesis. Mol Med Today. 5: 244–249. Tricker AR and Preussmann R (1988). The occurrence of N-nitro compounds in zarda tobacco.Cancer Lett., 42, 113–118. Triggiani M, Granata F, Giannattasio G and Marone G (2005). Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. J. Allergy Clin. Immunol. 116: 1000–1006. Tyroller S, Zwickenpflug W, Thalheim C, and Richter E (2005). Acute and subacute effects of tobacco alkaloids, tobacco-specific nitrosamines and phenethyl isothiocyanate on N'-nitrosonornicotine metabolism in rats. Toxicology. 215: 245-253. Ueda T, Ikegami M, Jobe A (1994). Surfactant subtypes: in vitro conversion, in vivo function and effects of serum proteins. Am. J. Respir. Crit. Care Med. 149 1254–1259. Uhlén M, et al (2005). A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol. Cell Proteomics 4: 1920–1932. Van Golde LM, Batenburg JJ, Robertson B (1988). The pulmonary surfactant system: biochemical aspects and functional significance. Physiol. Rev. 68: 374-455. Van Meer G, Voelker DR, Feigenson GW (2008). Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9: 112–124. Vanderbilt JN, Mager EM, Allen L, Sawa T, Wiener-Kronish J, Gonzalez R, Dobbs LG (2003). CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury. Am J Respir Cell Mol Biol 29: 661–668. Veldhuizen R, Nag K, Orgeig S, Possmayer F (1998). The role of lipids in pulmonary surfactant.

Biochim Biophys Acta 1408: 90–108. Vijayaraj P, Sabarirajan J, Nachiappan V (2011a).Enhanced phospholipase B activity and alteration of phospholipids and neutral lipids in Saccharomyces cerevisiae exposed to N-nitrosonornicotine. Antonie Van Leeuwenhoek, 99, 567-577. Vijayaraj P, Sabarirajan J, Nachiappan V (2011b).Impaired phospholipid metabolism in Saccharomyces cerevisiae by increased phospholipase B activity induced by 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone. Toxicological and Environmental Chemistry

(Accepted Manuscript). Villar J, Edelson JD, Post M, Mullen JB, Slutsky AS (1993). Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury. Am. Rev.

Respir. Dis. 147: 177–181. Von Neergaard K: Neue Auffassungen Uber einen Grundbegriff der Atemmechanik: Retracktionskraft der Lunge, Abhangig von der berflachenspunnung in den Alveolen. Z Gesamte Exp Med 1929; 66:373-394 Von Wichert P, Kohl FV (1977). Decreased dipalmitoyllecithin content found in lung specimens from patients with so-called shock-lung. Intens Care Med.3: 27–30. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJ, Barth PG (2000). Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Biophys

Res Commun. 279: 378-382.

Bibliography

145

VN’s Lab, BDU

Wade KC, Guttentag SH, Gonzales LW, Maschhoff KL, Gonzales J, Kolla V, Singhal S, Ballard PL (2006). Gene induction during differentiation of human pulmonary type II cells in vitro. Am J Respir Cell Mol Biol 34: 727–737.

Wagner S, and Paltauf F (1994) Generation of glycerophospholipid molecular species in the yeast Saccharomyces cerevisiae. Fatty acid pattern of phospholipid classes and selective acyl turnover at sn-1 and sn-2 positions. Yeast 10: 1429–1437. Wang Z, Gurel O, Baatz JE, Notter RH (1996). Differential activity and lack of synergy of lung surfactant proteins SP-B and SP-C in interactions with phospholipids. J. Lipid Res. 37: 1749–1760. Ware LB, Matthay MA (2000). The acute respiratory distress syndrome. N Engl J Med. 342:1334–1349. Weaver TE (1998). Synthesis, processing and secretion of surfactant proteins B and C. Biochim

Biophys Acta. 1408: 173-9. Weinrauch Y, Elsbach P, Madsen LM, Foreman A, Weiss J (1996). The potent anti- Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2. J.

Clin. Invest. 97: 250–257. Whitsett JA, Wert SE, Weaver TE (2010). Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med. 61, 105-119. Willers S, Attewell R, Bensryd I, Schutz A, Skarping A, Vahter M (1992). Exposure to environmental tobacco smoke in the household and urinary cotinine excretion, heavy metals retention and lung function. Arch Environ Health. 47: 357–363. Wirtz HR, Schmidt M (1996). Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture. Eur Respir J. 9: 24-32. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, Tetley TD (2004). Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol 30: 500–509. Wright JR (2005). Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 5: 58–68. Wright SM, Hockey PM, Enhorning G, Strong P, Reid KB, Holgate ST, Djukanovic R, Postle AD (2000). Altered airway surfactant phospholipid composition and reduced lung function in asthma. J Appl Physiol, 89, 1283-1292. Wu Y, Singer M, Thouron F, Alaoui-El-Azher M, Touqui L (2002). Effect of surfactant on pulmonary expression of type IIA PLA(2) in an animal model of acute lung injury. Am J Physiol Lung

Cell Mol Physiol. 282: 743–750. Wu YZ, Medjane S, Chabot S, Kubrusly FS, Raw I, Chignard M, Touqui L (2003). Surfactant protein-A and phosphatidylglycerol suppress type IIA phospholipase A2 synthesis via nuclear factor -kappaB. Am. J. Respir. Crit. Care Med. 168: 692–699. Wüstneck R, Perez-Gil J, Wüstneck N, Cruz A, Fainerman VB, Pison U (2005). Interfacial properties of pulmonary surfactant layers. Adv. Colloid. Interface Sci. 117: 33–58. Wurtemberger G, Herceg R, Matthys H, Ferber E, Costabel U (1990). [Surfactant phospholipids in bronchoalveolar lavage fluid in smokers with healthy lungs and non-smokers].

Pneumologie 44: 310-311.

Bibliography

146

VN’s Lab, BDU

Yamashita A, Sugiura T, Waku K (1997) Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells. J Biochem 122: 1-16. Yang Y, Cao J, Shi Y (2004).Identification and characterization of a gene encoding human LPGAT1, an endoplasmic reticulum-associated lysophosphatidylglycerol acyltransferase. J Biol

Chem. 279: 55866-55874. Yoshida T, Tuder RM (2007). Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev. 87:1047-1082. Young SL, Fram EK, Spain CL, Larson EW (1991). Development of type II pneumocytes in rat lung.

Am J Physiol 260, L113–L122. Zetterberg G, Curstedt T, Eklund A (1995). A possible alteration of surfactant in broncho-alveolar lavage fluid from healthy smokers compared to non-smokers and patients with sarcoidosis. Sarcoidosis 12: 46-50.